Anti-tumor necrosis factor-α induction therapy for patients with active inflammatory bowel disease during pregnancy is effective and safe

被引：0
|
作者：
Macisaac, M. [1 ]
Rowe, S. [1 ]
Ross, A. [1 ]
Flanagan, E. [1 ]
Julsgaard, M. [3 ]
Bell, S. [2 ]
机构：
[1] St Vincents Hosp, Dept Gastroenterol, Melbourne, Vic, Australia
[2] Monash Hlth, Dept Gastroenterol, Melbourne, Vic, Australia
[3] Aarhus Univ Hosp, Dept Hepatol & Gastroenterol, Aarhus, Denmark
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
339
引用
收藏
页码：147 / 148
页数：2
相关论文
共 50 条
  • [1] Safety of anti-tumor necrosis factor therapy during pregnancy in patients with inflammatory bowel disease
    Androulakis, Ioannis
    Zavos, Christos
    Christopoulos, Panagiotis
    Mastorakos, George
    Gazouli, Maria
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (47) : 13205 - 13211
  • [2] Safety of anti-tumor necrosis factor therapy during pregnancy in patients with inflammatory bowel disease
    Ioannis Androulakis
    Christos Zavos
    Panagiotis Christopoulos
    George Mastorakos
    Maria Gazouli
    World Journal of Gastroenterology, 2015, 21 (47) : 13205 - 13211
  • [3] Clinical Features of Active Tuberculosis Developed During Anti-Tumor Necrosis Factor-α Therapy in Patients With Inflammatory Bowel Diseases
    Choi, Chang Hwan
    Lee, Jang Wook
    GASTROENTEROLOGY, 2015, 148 (04) : S231 - S231
  • [4] Anti-tumor necrosis factor-α therapy may not be safe during pregnancy in women with inflammatory bowel disease: an updated meta-analysis and systematic review
    Huang, Wei
    Zhang, Xinxing
    Zhang, Li
    Dai, Xiaosong
    Chen, Heping
    Xie, Qin
    BMC PREGNANCY AND CHILDBIRTH, 2024, 24 (01)
  • [5] Clinical features of active tuberculosis that developed during anti-tumor necrosis factor therapy in patients with inflammatory bowel disease
    Lee, Jang Wook
    Choi, Chang Hwan
    Park, Ji Hoon
    Kim, Jeong Wook
    Kang, Sang Bum
    Koo, Ja Seol
    Kim, Young-Ho
    Kim, You Sun
    Joo, Young Eun
    Chang, Sae Kyung
    INTESTINAL RESEARCH, 2016, 14 (02) : 146 - 151
  • [6] The role of anti-tumor necrosis factor-α therapy in Pyoderma gangrenosum associated with inflammatory bowel disease
    Reguiai, Ziad
    Grange, Florent
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2007, 8 (02) : 67 - 77
  • [7] The Role of Anti-Tumor Necrosis Factor-α Therapy in Pyoderma Gangrenosum Associated with Inflammatory Bowel Disease
    Ziad Reguiaï
    Florent Grange
    American Journal of Clinical Dermatology, 2007, 8 : 67 - 77
  • [8] Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease
    Frank Hoentjen
    Ad A van Bodegraven
    World Journal of Gastroenterology, 2009, 15 (17) : 2067 - 2073
  • [9] Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease
    Hoentjen, Frank
    Van Bodegraven, Ad A.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (17) : 2067 - 2073
  • [10] Effects of Discontinuing Anti-Tumor Necrosis Factor Therapy During Pregnancy on the Course of Inflammatory Bowel Disease and Neonatal Exposure
    Zelinkova, Zuzana
    van der Ent, Cokkie
    Bruin, Karlien F.
    van Baalen, Onno
    Vermeulen, Hestia G.
    Smalbraak, Herman J. T.
    Ouwendijk, Rob J.
    Hoek, Aad C.
    van der Werf, Sjoerd D.
    Kuipers, Ernst J.
    van der Woude, C. Janneke
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (03) : 318 - 321
12345